Sterile Wipes
VAI produces high quality sterile wipers that are suited for use in any cleanroom environment. Visit our website or contact your local VAI representative for more information.
VAI features a complete range of dry & saturated, sterile wipers for use in any cleanroom environment. Our wipers are knitted with continuous monofilament polyester and are cut using "FocusEdge" cutting technology. Every wipe that VAI produces is available with the same material for consistency and inexpensive validation.
Materials used in our wipers are pre-cleaned and de-linted, then, put though a cleanroom laundry process and dried with a 1 UPLA air stream. The wipers are packaged into bags suitable for use in an ISO Class 4 area and labelled with lot number and expiration. All sterile wipers are sterilized via gamma irradiation at a 10-6 SAL or aseptically filled into sterile components. Subsequently, the wipers are lot USP sterility tested and quality assurance tested to specifications defined by IEST and ASTM. All shipments are delivered with lot specific documentation.
VAI's high quality sterile wipers are available in WipeDown® dry wipes, Process2Wipe® USP IPA and WFI Quality Water, HYPO-CHLOR® sterile sodium hypochlorite, STERI-PEROX® sterile hydrogen peroxide, DEC-CLEAN® RTU reside remover, individually packaged IPA wipes, ALCHO-WIPES® and ALCOH-GLOVES®, individually packaged ethanol STER-AHOL wipes, and STEEL-BRIGHT® Wipes for stainless steel cleaning. All of VAI's wipes are validated for sterility and shelf life.
Contact Details:
Veltek Associates, Inc.
Website: www.sterile.com
E-mail: vai@sterile.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of Forced Degradation in Method Development, Manufacturability, and CMC Strategy
April 28th 2025Forced degradation studies are critical in biologics development, particularly for monoclonal antibodies (mAbs). These studies simulate long-term environmental stressors to uncover degradation pathways and ensure the stability of critical quality attributes (CQAs), aiding in robust chemistry, manufacturing, and controls (CMC) strategies and regulatory compliance.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
